Detailed bleeding characteristics of first MB or first CRB in the full cohort (overall), and in those with and those without therapeutic anticoagulation
| . | Overall . | Therapeutic anticoagulation . | No therapeutic anticoagulation . | |||
|---|---|---|---|---|---|---|
| MB (n = 70) . | CRB (n = 139) . | MB (n = 27) . | CRB (n = 43) . | MB (n = 43) . | CRB (n = 96) . | |
| Site of bleeding | ||||||
| Cutaneous | 1 (1.4) | 9 (6.5) | 0 | 3 (7.0) | 1 (2.3) | 6 (6.3) |
| Epistaxis | 2 (2.9) | 12 (8.6) | 1 (3.7) | 5 (11.6) | 1 (2.3) | 7 (7.3) |
| Intracranial | 8 (11.4) | 7 (5.0) | 4 (14.8) | 4 (9.3) | 4 (9.3) | 3 (3.1) |
| GI | 42 (60.0) | 64 (46.0) | 19 (70.4) | 22 (51.2) | 23 (53.5) | 42 (43.8) |
| Lower GI | 15 (21.4) | 30 (21.6) | 7 (25.9) | 8 (18.6) | 8 (18.6) | 22 (22.9) |
| Upper GI | 27 (38.6) | 34 (24.4) | 12 (44.4) | 14 (32.6) | 15 (34.9) | 20 (20.8) |
| Oropharyngeal | 8 (11.4) | 15 (10.8) | 0 | 1 (2.3) | 8 (18.6) | 13 (13.5) |
| Other | 3 (3.3) | 5 (3.6) | 1 (3.7) | 1 (2.3) | 2 (4.7) | 4 (4.2) |
| Pulmonary | 2 (2.9) | 11 (7.9) | 1 (3.7) | 3 (7.0) | 1 (2.3) | 8 (8.3) |
| Urinary tract | 4 (5.7) | 12 (8.6) | 1 (3.7) | 3 (7.0) | 3 (7.0) | 9 (9.4) |
| Vaginal | 0 | 4 (2.9) | 0 | 1 (2.3) | 0 | 3 (3.1) |
| Tumor bleeding∗ | 23 (32.9) | 42 (30.2) | 9 (33.3) | 11 (25.6) | 14 (32.6) | 30 (31.3) |
| Recent history of surgery or invasive procedure | 3 (4.3) | 5 (3.6) | 1 (3.7) | 1 (2.3) | 2 (4.7) | 4 (4.2) |
| Traumatic | 6 (8.6) | 7 (5.0) | 1 (3.7) | 3 (7.0) | 3 (7.0) | 4 (4.2) |
| Incidental† | 0 | 1 (0.7) | 0 | 0 | 0 | 1 (1.0) |
| Fatal | 7 (10.0) | 7 (5.0) | 1 (3.7) | 1 (2.3) | 6 (13.9) | 6 (6.3) |
| . | Overall . | Therapeutic anticoagulation . | No therapeutic anticoagulation . | |||
|---|---|---|---|---|---|---|
| MB (n = 70) . | CRB (n = 139) . | MB (n = 27) . | CRB (n = 43) . | MB (n = 43) . | CRB (n = 96) . | |
| Site of bleeding | ||||||
| Cutaneous | 1 (1.4) | 9 (6.5) | 0 | 3 (7.0) | 1 (2.3) | 6 (6.3) |
| Epistaxis | 2 (2.9) | 12 (8.6) | 1 (3.7) | 5 (11.6) | 1 (2.3) | 7 (7.3) |
| Intracranial | 8 (11.4) | 7 (5.0) | 4 (14.8) | 4 (9.3) | 4 (9.3) | 3 (3.1) |
| GI | 42 (60.0) | 64 (46.0) | 19 (70.4) | 22 (51.2) | 23 (53.5) | 42 (43.8) |
| Lower GI | 15 (21.4) | 30 (21.6) | 7 (25.9) | 8 (18.6) | 8 (18.6) | 22 (22.9) |
| Upper GI | 27 (38.6) | 34 (24.4) | 12 (44.4) | 14 (32.6) | 15 (34.9) | 20 (20.8) |
| Oropharyngeal | 8 (11.4) | 15 (10.8) | 0 | 1 (2.3) | 8 (18.6) | 13 (13.5) |
| Other | 3 (3.3) | 5 (3.6) | 1 (3.7) | 1 (2.3) | 2 (4.7) | 4 (4.2) |
| Pulmonary | 2 (2.9) | 11 (7.9) | 1 (3.7) | 3 (7.0) | 1 (2.3) | 8 (8.3) |
| Urinary tract | 4 (5.7) | 12 (8.6) | 1 (3.7) | 3 (7.0) | 3 (7.0) | 9 (9.4) |
| Vaginal | 0 | 4 (2.9) | 0 | 1 (2.3) | 0 | 3 (3.1) |
| Tumor bleeding∗ | 23 (32.9) | 42 (30.2) | 9 (33.3) | 11 (25.6) | 14 (32.6) | 30 (31.3) |
| Recent history of surgery or invasive procedure | 3 (4.3) | 5 (3.6) | 1 (3.7) | 1 (2.3) | 2 (4.7) | 4 (4.2) |
| Traumatic | 6 (8.6) | 7 (5.0) | 1 (3.7) | 3 (7.0) | 3 (7.0) | 4 (4.2) |
| Incidental† | 0 | 1 (0.7) | 0 | 0 | 0 | 1 (1.0) |
| Fatal | 7 (10.0) | 7 (5.0) | 1 (3.7) | 1 (2.3) | 6 (13.9) | 6 (6.3) |